Health Care: Drugs

Hyperion Therapeutics Inc (HPTX: NASDAQ)

$24.71 n/a | n/a%
04/17/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 24.71
52 Week High 32.98
52 Week Low 15.92
Avg. Daily Vol. (Mil) 0.10
Beta (3 year) 0.00
Share Related Items
Mkt Cap (Mil) 498.64
Shares Out (Mil) 20.18
Float (Mil) 9.45
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.30
Current Ratio 5.50
LT Debt/ Equity 0.02
Total Debt / Equity 0.07
Valuation Ratios
Price Earnings 30.80
Price/Sales 11.82
Price/Book 4.17
Price/Cash Flow 24.30
Per Share Data
Earnings 0.80
Sales 2.09
Book Value 5.93
Cash Flow 1.02
Business Summary
Hyperion Therapeutics Inc is a commercial-stage biopharmaceutical company that is engaged into the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology.
General Information
601 Gateway Boulevard
Suite 200
South San Francisc, CA 94080
www.hyperiontx.com
Industry : Drugs
Sector: Health Care
Employees: 54
CEO: Donald J. Santel
Short Interest
Current Month (Mil) 0.70
Previous Month (Mil) 0.74
Short Interest Ratio (Days) 5.40
Management Effectiveness
Return on Equity 13.90
Return on Assets 11.70
Return on Investments 13.60
Profitability
Gross Margin 85.90
EBIT Margin 43.20
Profit Margin 39.40

Portfolios with HPTX

Latest HPTX Headlines from TheStreet

More Financial News for HPTX

Press Releases for HPTX

See All Press Releases

Partner Headlines for HPTX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter